New study aims to predict preeclampsia with simple blood test
NCT ID NCT06249178
First seen Jan 05, 2026 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This study is observing 1,000 pregnant people at risk for preeclampsia who are taking aspirin as part of their care. Researchers will collect blood samples up to four times during pregnancy to analyze tiny particles called extracellular vesicles. The goal is to find protein patterns that show how well the placenta is working and how it responds to aspirin, which could lead to better monitoring and prevention of preeclampsia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
RECRUITINGColumbus, Ohio, 43210, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.